Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T1D progression is associated with loss of CD3+CD56+ regulatory T cells that control CD8+ T cell effector functions.
Terrazzano G, Bruzzaniti S, Rubino V, Santopaolo M, Palatucci AT, Giovazzino A, La Rocca C, de Candia P, Puca A, Perna F, Procaccini C, De Rosa V, Porcellini C, De Simone S, Fattorusso V, Porcellini A, Mozzillo E, Troncone R, Franzese A, Ludvigsson J, Matarese G, Ruggiero G, Galgani M. Terrazzano G, et al. Among authors: ludvigsson j. Nat Metab. 2020 Feb;2(2):142-152. doi: 10.1038/s42255-020-0173-1. Epub 2020 Feb 17. Nat Metab. 2020. PMID: 32500117 Free PMC article.
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease.
Bruzzaniti S, Piemonte E, Mozzillo E, Bruzzese D, Lepore MT, Carbone F, de Candia P, Strollo R, Porcellini A, Marigliano M, Maffeis C, Bifulco M, Ludvigsson J, Franzese A, Matarese G, Galgani M. Bruzzaniti S, et al. Among authors: ludvigsson j. Diabetologia. 2022 Aug;65(8):1390-1397. doi: 10.1007/s00125-022-05724-3. Epub 2022 May 25. Diabetologia. 2022. PMID: 35610521
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
Strollo R, Vinci C, Man YKS, Bruzzaniti S, Piemonte E, Alhamar G, Briganti SI, Malandrucco I, Tramontana F, Fanali C, Garnett J, Buccafusca R, Guyer P, Mamula M, James EA, Pozzilli P, Ludvigsson J, Winyard PG, Galgani M, Nissim A. Strollo R, et al. Among authors: ludvigsson j. Diabetologia. 2023 Jan;66(1):132-146. doi: 10.1007/s00125-022-05812-4. Epub 2022 Oct 7. Diabetologia. 2023. PMID: 36207582 Free PMC article.
Therapy with GAD in diabetes.
Ludvigsson J. Ludvigsson J. Diabetes Metab Res Rev. 2009 May;25(4):307-15. doi: 10.1002/dmrr.941. Diabetes Metab Res Rev. 2009. PMID: 19267332 Review.
1,293 results